Literature DB >> 14990521

Cognitive-behavioural therapy in first-episode and early schizophrenia. 18-month follow-up of a randomised controlled trial.

Nicholas Tarrier1, Shôn Lewis, Gillian Haddock, Richard Bentall, Richard Drake, Peter Kinderman, David Kingdon, Ronald Siddle, Julie Everitt, Karen Leadley, Andy Benn, Katy Grazebrook, Cliff Haley, Shahid Akhtar, Linda Davies, Steve Palmer, Graham Dunn.   

Abstract

BACKGROUND: The initial phase of a trial of cognitive-behavioural therapy (CBT) for acutely ill patients with schizophrenia of recent onset showed that it speeded recovery. AIMS: To test the hypothesis that CBT in addition to treatment as usual (TAU) during the first or second acute episode of schizophrenia will confer clinical benefit over a follow-up period.
METHOD: This was an 18-month follow-up of a multicentre prospective trial of CBT or supportive counselling administered as an adjunct to TAU, compared with TAU alone, for patients hospitalised for an acute episode of schizophrenia of recent onset. Primary outcomes were total and positive symptom scales, time to relapse and re-hospitalisation.
RESULTS: There were significant advantages for CBT and supportive counselling over TAU alone on symptom measures at 18 months but no group difference was seen for relapse or re-hospitalisation. There was a significant centre-treatment interaction, reflecting centre differences in the effect of introducing either treatment, but not in the comparison of CBT and supportive counselling. Medication dosage and compliance did not explain group differences.
CONCLUSIONS: Adjunctive psychological treatments can have a beneficial long-term effect on symptom reduction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14990521     DOI: 10.1192/bjp.184.3.231

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  35 in total

Review 1.  Elderly patients with schizophrenia and depression: diagnosis and treatment.

Authors:  Kandi Felmet; Sidney Zisook; John W Kasckow
Journal:  Clin Schizophr Relat Psychoses       Date:  2011-01

2.  Predictors of clinical and social outcomes following involuntary hospital admission: a prospective observational study.

Authors:  Stefan Priebe; Christina Katsakou; Ksenija Yeeles; Tim Amos; Richard Morriss; Duolao Wang; Til Wykes
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-12-22       Impact factor: 5.270

Review 3.  Recovery in schizophrenia: reality or mere slogan.

Authors:  Natalie B Slopen; Patrick W Corrigan
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

4.  Efficacy of psychological therapy in schizophrenia: conclusions from meta-analyses.

Authors:  Mario Pfammatter; Ulrich Martin Junghan; Hans Dieter Brenner
Journal:  Schizophr Bull       Date:  2006-08-11       Impact factor: 9.306

Review 5.  Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis.

Authors:  Mario Alvarez-Jiménez; Alexandra G Parker; Sarah E Hetrick; Patrick D McGorry; John F Gleeson
Journal:  Schizophr Bull       Date:  2009-11-09       Impact factor: 9.306

Review 6.  Early intervention for psychosis.

Authors:  Max Marshall; John Rathbone
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

Review 7.  Antipsychotic medication for early episode schizophrenia.

Authors:  John Bola; Dennis Kao; Haluk Soydan
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

8.  Have the potential benefits of CBT for severe mental disorders been undersold?

Authors:  Kim T Mueser; Shirley M Glynn
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

Review 9.  [Evidence basis of psychotherapy for schizophrenia patients in Germany].

Authors:  B Puschner; R Vauth; F Jacobi; T Becker
Journal:  Nervenarzt       Date:  2006-11       Impact factor: 1.214

10.  Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for intervention.

Authors:  Richard J Drake; Merete Nordentoft; Gillian Haddock; Celso Arango; W Wolfgang Fleischhacker; Birte Glenthøj; Marion Leboyer; Stefan Leucht; Markus Leweke; Phillip McGuire; Andreas Meyer-Lindenberg; Dan Rujescu; Iris E Sommer; René S Kahn; Shon W Lewis
Journal:  Schizophr Bull       Date:  2015-03-05       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.